Intellectual Property UK

  • April 10, 2024

    EUIPO Wrongly Skimmed Dairy Biz's 'Rebell' TM, Court Says

    A European Union court has restored a dairy company's "Rebell" protection, ruling on Wednesday that intellectual property officials failed to explain why they narrowed the scope of the trademark for lack of use amid a beef company's protests.

  • April 09, 2024

    Chinese Co. Wants To Nix Abbott's 3D TM For Diabetes Tech

    A group of Chinese companies hit back at Abbott's claims that they copied a 3D trademark for a continuous glucose monitoring device, arguing that the product's features shouldn't be protected in the first place.

  • April 09, 2024

    Canine Toilet Biz City Doggo Bites Back At Rival's TM Claim

    A company that makes grass toilets for dogs has hit back at its competitor, after the rival business accused it of ripping off its natural pee patch featured on the BBC TV show "Dragons' Den."

  • April 16, 2024

    Freeths Hires Murgitroyd Atty As Patents Director

    Freeths LLP has appointed a new director of patents with more than 16 years of experience advising clients such as Nokia and Rolls-Royce, marking the latest addition to the firm's growth strategy.

  • April 09, 2024

    Kigen, Thales Settle Dispute Over SIM Card Standard Patent

    A U.K. tech company and a subsidiary of French electronic giant Thales Group have settled their dispute over fair licensing terms for standard-essential technology used to remotely activate SIM cards in mobile phones.

  • April 09, 2024

    Medical Device Maker Fights Kidney Stone Tech Patent Claim

    A U.K. medical device maker has denied that its bladder stone-removing technology infringes a Chinese rival's patent for a similar-looking product, saying it will continue to put its devices on the market.

  • April 09, 2024

    Gaming Co. Fires Back In 'Burning Hot' TM Clash With Rival

    A casino gaming business has hit back at a challenge to the validity of its "Mini Burning Hot" trademark, arguing that its rival is trying to relitigate earlier proceedings and alleging that the competitor's U.K. trademark protections are invalid.

  • April 08, 2024

    Nivea Wins 'KiiLTO' TM Spat Over Reputational Risks

    Nivea brand owner Beiersdorf on Monday successfully opposed a Finnish chemical products manufacturer's trademark "KiiLTO Airi" after European officials found the mark likely to "tarnish" the skincare brand's reputation.

  • April 08, 2024

    Netherlands Top Court Says No Copyright In Balloon Filler

    The Netherlands' top court rejected a product developer's bid to copyright its water balloon filler, "Bunch-O-Balloons," after finding that most of the inventor's decisions were technical rather than spurred by creativity.

  • April 08, 2024

    Ferrero Tastes Defeat In Nutella TM Opposition

    Ferrero can't stop a man from registering a trademark for "Mozartella" after European officials ruled that buyers wouldn't confuse it with the Nutella chocolate brand, even though he used it to market chocolate spreads.

  • April 08, 2024

    Packaging Biz Seals EPO Win In Paper-Coating Patent Feud

    A packaging company has fought off a rival's challenge to its patent for oil-resistant paper after persuading a European Patent Office appeals panel that the makeup of the binding material for its compound was inventive.

  • April 08, 2024

    Biotech Biz Sensorion Raises €15M From Existing Investors

    French biotech firm Sensorion SA said Monday that it has raised €15 million ($16.2 million) through a share offering to existing institutional investors to fund its research and development until the end of 2025.

  • April 05, 2024

    Bayer Can't Block Generic Xarelto, And Has Patent Nixed

    Bayer can't stop a French generic-drug maker from putting a cheaper version of its blockbuster blood thinner Xarelto on pharmacy shelves, after a French court nixed its dosage patent.

  • April 05, 2024

    Edwards Gets EPO To Nix Abbott Unit's Heart Valve Patent

    Edwards Lifesciences has persuaded a European Patent Office appeals panel to block an Abbott unit's prosthetic heart valve patent application, after proving that the design was not new.

  • April 05, 2024

    Amazon Cloud Computing Patent Powered Down On Appeal

    Amazon has lost its fight to patent a method of pre-launching cloud computing services, with a European patent authority appeals board concluding that the invention did not take an inventive step beyond existing technology.

  • April 05, 2024

    UK Litigation Roundup: Here's What You Missed In London

    This past week in London has seen the BBC sued by former Georgian defense minister David Kezerashvili, Russian businessman Ildar Sharipov file a defamation claim against the publisher of the Liverpool Echo newspaper, MEX Group Worldwide sue Barclays and NatWest, and a climbing gear company hit retailer Next with a claim of copyright infringement. Here, Law360 looks at these and other new claims in the U.K.

  • April 05, 2024

    Counterfeiters Flourish In Wake Of COVID, IP Body Says

    The COVID-19 pandemic resulted in a global uptick in the trade of counterfeit goods, beginning with fake healthcare products but spreading to other areas of trade as virtually all shopping moved online, a new report found Friday.

  • April 05, 2024

    3 Questions For Mishcon's David Rose And Jeremy Hertzog

    Clients look for many skills in intellectual property lawyers, but scientific expertise is not necessarily one of them, according to David Rose of Mishcon de Reya. Here, Rose and his colleague Jeremy Hertzog talk IP with Law360.

  • April 04, 2024

    Getty Says Stability AI Plays 'Active Role' In Making AI Images

    Stock images giant Getty Images has clapped back at the makers of the popular Stable Diffusion software in the companies' U.K. copyright dispute, saying Stability AI cannot claim that any potentially infringing image the generative AI model creates is due to the user's input alone.

  • April 04, 2024

    Henkel Loses Bid To Sweep Away Rival's Cleaning TM

    A Romanian cleaning product company has won its trademark appeal for its "Clinium" logo, after a European appellate board found that buyers would not conflate the sign with German rival Henkel's "Clin" trademark.

  • April 04, 2024

    Juul Can't Dodge UPC Vape Feud Over Rival's Admin Error

    Juul can't dash a challenge to five of its vaping patents even though its rival NJOY listed the wrong company in its initial papers, an appeals panel has said, giving the competing company the green light to tweak its claim.

  • April 04, 2024

    Velcro-Selling Co. Sues Rival Over Amazon Complaints

    A Northern Irish Velcro product distributor has accused a rival of spreading false rumors about its goods and putting the company in Amazon's bad books by returning several purchases and claiming they were "inauthentic."

  • April 04, 2024

    Gambling Biz Says Rival, Ex-Employees Copied Game Code

    An online gambling company has sued two former members of staff and its rival for allegedly plagiarizing copyrighted source code for its "Slingo" online betting game to produce several competing products.

  • April 03, 2024

    Genmab Builds Oncology Portfolio With $1.8B Deal

    Danish biotechnology company Genmab announced Wednesday that it would acquire private cancer drugmaker ProfoundBio for $1.8 billion in cash, a move set to beef up Genmab's oncology portfolio and position the company as a competitor to other biotech companies that have made similar deals in the antibody drug conjugate space in recent months.

  • April 03, 2024

    Jacob & Co. Can't Get TM Over Name For Alcohol Venture

    High-end jeweler Jacob & Co. can't register a trademark of its name over spirits after European officials ruled that a German company selling "Jacobi"-branded spirits had already established a presence in the market.

Expert Analysis

  • Looking Ahead At AI Regulation In The EU And UK

    Author Photo

    With AI regulation agreed upon in Europe and a U.K. regulatory authority on the horizon, organizations developing AI should consider deploying governance, addressing accountability and establishing internal guardrails to achieve a balanced approach to responsible innovation while managing risk, says Chris Eastham at Fieldfisher.

  • 2024 Will Be A Busy Year For Generative AI And IP Issues

    Author Photo

    In light of increased litigation and policy proposals on balancing intellectual property rights and artificial intelligence innovation, 2024 is shaping up to be full of fast-moving developments that will have significant implications for AI tool developers, users of such tools and rights holders, say lawyers at Mishcon de Reya.

  • The Most-Read Law360 UK Guest Articles Of 2023

    Author Photo

    Benefits of the new EU Unified Patent Court, artificial intelligence regulation and M&A trends amid rising inflation were among the hot topics U.K. Expert Analysis articles explored this year.

  • 9 Takeaways From The UPC's First 6 Months In Session

    Author Photo

    Six months after its opening, the Unified Patent Court has established itself as an appealing jurisdiction, with its far territorial reach, short filing deadlines and extremely quick issuance of preliminary injunctions showing that it is well-prepared to provide for rapid legal clarity, says Antje Brambrink at Finnegan.

  • The Year In FRAND: What To Know Heading Into 2024

    Author Photo

    In 2023, there were eight significant developments concerning the fair, reasonable and nondiscriminatory patent licensing regime that undergirds technical standardization, say Tom Millikan and Kevin Zeck at Perkins Coie.

  • How Int'l Student-Athlete Law Would Change The NIL Game

    Author Photo

    Recently proposed legislation to allow international student-athletes the opportunity to profit from their name, image and likeness without violating their F-1 nonimmigrant student visa status represents a pivotal step in NIL policy, and universities must assess and adapt their approaches to accommodate unique immigration concerns, say attorneys at Phelps Dunbar.

  • Series

    Children's Book Writing Makes Me A Better Lawyer

    Author Photo

    Becoming a children's book author has opened doors to incredible new experiences of which I barely dared to dream, but the process has also changed my life by serving as a reminder that strong writing, networking and public speaking skills are hugely beneficial to a legal career, says Shaunna Bailey at Sheppard Mullin.

  • How The PTAB Landscape Shifted In 2023

    Author Photo

    Attorneys at Finnegan consider the impact of noteworthy Patent Trial and Appeal Board developments in 2023, including rulemaking, litigation, precedential decisions and director reviews that affected PTAB practice, and offer a reference for examining future proceedings and strategies.

  • How 'Copyleft' Licenses May Affect Generative AI Output

    Author Photo

    Open-source software and the copyleft licenses that support it, whereby derivative works must be made available for others to use and modify, have been a boon to the development of artificial intelligence, but could lead to issues for coders who use AI to help write code and may find their resulting work exposed, says William Dearn at HLK.

  • UPC Decision Highlights Key Security Costs Questions

    Author Photo

    While the Unified Patent Court recently ordered NanoString to pay €300,000 as security for Harvard's legal costs in a revocation action dispute, the decision highlights that the outcome of a security for costs application will be highly fact-dependent and that respondents should prepare to set out their financial position in detail, says Tom Brazier at EIP.

  • IP Ruling Could Pave Way For AI Patents In UK

    Author Photo

    If implemented by the U.K. Intellectual Property Office, the High Court's recent ruling in Emotional Perception AI v. Comptroller-General of Patents, holding that artificial neural networks can be patented, could be a first step to welcoming AI patents in the U.K., say Arnie Francis and Alexandra Brodie at Gowling.

  • Why It's Urgent For Pharma Cos. To Halt Counterfeit Meds

    Author Photo

    With over 10.5 million counterfeit medicines seized in the EU in 2023, it is vital both ethically and commercially that pharmaceutical companies take steps to protect against such infringements, including by invoking intellectual property rights protection, says Lars Karnøe at Potter Clarkson.

  • Examining US And Europe Patent Disclosure For AI Inventions

    Author Photo

    As applicants before the U.S. Patent and Trademark Office and the European Patent Office increasingly seek patent protection for inventions relating to artificial intelligence, the applications may require more implementation details than traditional computer-implemented inventions, including disclosure of data and methods used to train the AI systems, say attorneys at Finnegan.

  • Incontinence Drug Ruling Offers Key Patent Drafting Lessons

    Author Photo

    In a long-awaited decision in Astellas v. Teva and Sandoz, an English court found that the patent for a drug used to treat overactive bladder syndrome had not been infringed, highlighting the interaction between patent drafting and litigation strategy, and why claim infringement is as important a consideration as validity, says George McCubbin at Herbert Smith.

  • EPO Decision Significantly Relaxes Patent Priority Approach

    Author Photo

    In a welcome development for patent applicants, a recent European Patent Office decision redefines the way that entitlement to priority is assessed, significantly relaxing the previous approach and making challenges to the right to priority in post-grant opposition proceedings far more difficult, say lawyers at Finnegan.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Intellectual Property UK archive.
Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!